UBS AM’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.51M | Sell |
191,606
-81,251
| -30% | -$1.07M | ﹤0.01% | 2045 |
|
|
2025
Q1 | $6M | Sell |
272,857
-6,268
| -2% | -$138K | ﹤0.01% | 1482 |
|
|
2024
Q4 | $7.45M | Buy |
279,125
+194,831
| +231% | +$5.2M | ﹤0.01% | 1398 |
|
|
2024
Q3 | $2.25M | Buy |
84,294
+4,426
| +6% | +$118K | ﹤0.01% | 1976 |
|
|
2024
Q2 | $1.44M | Buy |
79,868
+47,455
| +146% | +$855K | ﹤0.01% | 2172 |
|
|
2024
Q1 | $591K | Buy |
32,413
+8,800
| +37% | +$161K | ﹤0.01% | 2232 |
|
|
2023
Q4 | $258K | Buy |
+23,613
| New | +$258K | ﹤0.01% | 2456 |
|